Fact CheckerSign in

NCT07728370Not yet recruiting

RISE: Reducing Cancer and HIV Stigma Through Empowerment

Source: ClinicalTrials.gov · Last updated 27 Jul 2026

Brief summary (registry, in English)

This multilevel randomized behavioral study evaluates participant- and provider-level stigma-reduction interventions in Zambia. Participant-level intervention: Women living with cervical cancer and HIV (WLC+H ) are randomized in a 2×2 factorial design of storytelling versus neutral videos and storytelling versus neutral disclosure interventions to assess effects on quality of life, anxiety, and depressive symptoms. Provider-level intervention: Healthcare workers are randomized to storytelling or neutral videos to assess changes in stigma and compassion. The study also evaluates participant -reported stigma and satisfaction with care before and after implementation of the provider intervention.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
440 (estimated)
First submitted
10 Jul 2026
Start date
1 Sept 2026
Primary completion date
31 May 2030
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT07728370

What you commit to

  • Study type: Interventional
  • Planned participants: 440
  • From 1 Sept 2026 to the primary completion date, 31 May 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1.Inability to provide informed consent and presence of a major mental health disorder (e.g., schizophrenia or bipolar disorder), as determined by participant records or self-report.

Other

  • Patient-level intervention
  • Provider-level intervention
  • 1\. Inability to provide informed consent

Who the study is looking for

  • Patient-level intervention
  • Women diagnosed with cervical cancer and HIV (stage I-IV)
  • Receiving cancer treatment at the Cancer Disease Hospital in Zambia
  • Aged 18 or above 4. Able to speak in English (the official language in Zambia) or one of four local languages (Bemba, Nyanja, Tonga, Lozi) for cultural inclusivity
    • Provider-level intervention
    • 1\. Employment at the Cancer Disease Hospital in Lusaka, Zambia

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UT MD Anderson
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.